Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
37 studies found for:    "Porphyria"
Show Display Options
Rank Status Study
21 Recruiting Panhematin for Prevention of Acute Attacks of Porphyria Panhematin for Prevention of Acute Attacks of Porphyria
Conditions: Acute Intermittent Porphyria;   Hereditary Coproporphyria;   Variegate Porphyria
Interventions: Biological: Hemin for injection;   Other: Placebo
22 Completed Study of the Pathogenesis of Porphyria Cutanea Tarda
Condition: Porphyria Cutanea Tarda
Intervention:
23 Recruiting Clinical Diagnosis of Acute Porphyria
Conditions: Hereditary Coproporphyria (HCP);   Acute Intermittent Porphyria (AIP);   Variegate Porphyria (VP)
Intervention:
24 Completed Porphozym in the Treatment of Acute Attacks in AIP
Condition: Acute Intermittent Porphyria
Intervention: Drug: recombinant human porphobilinogen deaminase (Porphozym)
25 Completed Sorbent Therapy of the Cutaneous Porphyrias
Condition: Erythropoietic Protoporphyria
Intervention: Drug: Colestipol
26 Active, not recruiting Mitoferrin-1 Expression in Erythropoietic Protoporphyria (Porphyria Rare Disease Clinical Research Consortium (RDCRC))
Condition: Erythropoietic Protoporphyria (EPP)
Intervention:
27 Completed Diagnostic and Screening Study of Genetic Disorders
Conditions: Tay-Sachs Disease;   Porphyria, Erythropoietic;   Leukodystrophy, Globoid Cell;   Metabolism, Inborn Errors
Intervention:
28 Active, not recruiting Assessment of Intra-subject Variability in the Bioavailability of Chlorpromazine Hydrochloride
Conditions: Anti-Psychotic;   Management of Manifestations of Psychotic Disorders;   Treatment of Schizophrenia;   Control Nausea and Vomiting;   Relief of Restlessness and Apprehension Before Surgery;   Acute Intermittent Porphyria;   Adjunct in the Treatment of Tetanus;   Control Manifestations of the Manic Type of Mani-depressive Illness;   Relief of Intractable Hiccups
Intervention: Drug: Chlorpromazine Hydrochloride
29 Withdrawn Effect of Isoniazid on Protoporphyrin Levels in Erythropoietic Protoporphyria
Conditions: Erythropoietic Protoporphyria (EPP);   X Linked Erythropoietic Protoporphyria
Intervention: Drug: Isoniazid
30 Completed Phase III Study of L-Cysteine in Patients With Erythropoietic Protoporphyria
Condition: Erythropoietic Protoporphyria
Intervention: Drug: cysteine hydrochloride
31 Completed Study of Cysteine Hydrochloride for Erythropoietic Protoporphyria
Condition: Erythropoietic Protoporphyria
Intervention: Drug: cysteine hydrochloride
32 Recruiting Erythropoietic Protoporphyrias: Studies of the Natural History, Genotype-Phenotype Correlations, and Psychosocial Impact
Conditions: Erythropoietic Protoporphyria;   EPP;   X-Linked Protoporphyria;   XLP;   XLPP;   X-Linked Dominant Erythropoietic Protoporphyria;   XLEPP;   XLDP
Intervention:
33 Recruiting Oral Iron for Erythropoietic Protoporphyrias
Conditions: Erythropoietic Protoporphyria;   EPP;   X-linked Protoporphyria;   XLP
Intervention: Drug: Oral Iron
34 Unknown  Phase III Confirmatory Study in Erythropoietic Protoporphyria
Condition: Erythropoietic Protoporphyria
Interventions: Drug: Afamelanotide;   Drug: Placebo
35 Completed Phase II Confirmatory Study in Erythropoietic Protoporphyria (EPP)
Condition: Erythropoietic Protoporphyria
Interventions: Drug: Afamelanotide;   Drug: Placebo
36 Completed Phase III Confirmatory Study in Erythropoietic Protoporphyria (EPP)
Condition: Erythropoietic Protoporphyria
Interventions: Drug: Afamelanotide;   Drug: Placebo
37 Unknown  Does Exercise and Heat Increase the Lightsensibility in Patients With Erythropoietic Protoporphyria
Condition: Erythropoietic Protoporphyria
Interventions: Behavioral: exercise;   Behavioral: heat;   Procedure: red light illumination

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-37) Next Page   
Study has passed its completion date and status has not been verified in more than two years.